Aurinia Pharmaceuticals logo

Aurinia Pharmaceuticals Share Price Today

(NASDAQ: AUPH)

Aurinia Pharmaceuticals share price is $8.67 & ₹754.85 as on 6 Mar 2025, 2.30 'hrs' IST

$8.67

0.59

(7.3%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Aurinia Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Aurinia Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Aurinia Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Aurinia Pharmaceuticals share price movements

  • Today's Low: $8.18
    Today's High: $8.83

    Day's Volatility :7.42%

  • 52 Weeks Low: $4.71
    52 Weeks High: $10.67

    52 Weeks Volatility :55.86%

Aurinia Pharmaceuticals (AUPH) Returns

PeriodAurinia Pharmaceuticals IncSector (Health Care)Index (Russel 2000)
3 Months
-2.36%
3.7%
0.0%
6 Months
25.47%
-2.8%
0.0%
1 Year
57.07%
2.5%
0.0%
3 Years
-18.74%
12.9%
-11.6%

Aurinia Pharmaceuticals (AUPH) Key Statistics

in dollars & INR

Previous Close
$8.08
Open
$8.1
Today's High
$8.83
Today's Low
$8.175
Market Capitalization
$1.1B
Today's Volume
$2.9M
52 Week High
$10.67
52 Week Low
$4.71
Revenue TTM
$235.1M
EBITDA
$32.0M
Earnings Per Share (EPS)
$0.04
PE Ratio
202.0
Profit Margin
2.45%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
1.52%

How to invest in Aurinia Pharmaceuticals Stock (AUPH) from India?

It is very easy for Indian residents to invest directly in Aurinia Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Aurinia Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Aurinia Pharmaceuticals or AUPH on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Aurinia Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Aurinia Pharmaceuticals shares which would translate to 0.100 fractional shares of Aurinia Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Aurinia Pharmaceuticals, in just a few clicks!

Returns in Aurinia Pharmaceuticals (AUPH) for Indian investors in Rupees

The Aurinia Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Aurinia Pharmaceuticals investment value today

Current value as on today

₹1,62,130

Returns

₹62,130

(+62.13%)

Returns from Aurinia Pharmaceuticals Stock

₹57,065 (+57.07%)

Dollar Returns

₹5,065 (+5.06%)

Indian investors sentiment towards Aurinia Pharmaceuticals (AUPH)

-14%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Aurinia Pharmaceuticals Stock from India on INDmoney has decreased by -14% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Aurinia Pharmaceuticals

  • BlackRock Inc

    6.52%

  • TANG CAPITAL MANAGEMENT LLC

    6.14%

  • Armistice Capital, LLC

    4.66%

  • NEA Management Company, LLC

    2.89%

  • State Street Corp

    2.12%

  • Geode Capital Management, LLC

    1.28%

Analyst Recommendation on Aurinia Pharmaceuticals

Buy

    84%Buy

    15%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Aurinia Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
11
Hold
2
2
3
Sell
0
0
0

Analyst Forecast on Aurinia Pharmaceuticals Stock (AUPH)

What analysts predicted

Upside of 18.64%

Target:

$10.29

Current:

$8.67

Insights on Aurinia Pharmaceuticals Stock (Ticker Symbol: AUPH)

  • Price Movement

    In the last 7 days, AUPH stock has moved up by 14.8%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 67.77M → 59.86M (in $), with an average decrease of 11.7% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 14.35M → 1.42M (in $), with an average decrease of 90.0% per quarter
  • AUPH vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 9.4%
  • AUPH vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 69.7%
  • Price to Sales

    ForAUPH every $1 of sales, investors are willing to pay $5.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Aurinia Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Aurinia Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Aurinia Pharmaceuticals (AUPH) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Aurinia Pharmaceuticals Inc logo
8.24%
25.47%
57.07%
-18.74%
-43.92%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Aurinia Pharmaceuticals Inc logo
202.0
202.0
0.0
0.47
0.02
0.01
NA
2.68
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Aurinia Pharmaceuticals Inc logo
Buy
$1.1B
-43.92%
202.0
2.45%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Aurinia Pharmaceuticals

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, focuses on delivering therapies to treat autoimmune diseases with unmet medical needs in the United States. It offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. The company also develops AUR200, a dual inhibitor of B cell activating factor and a proliferation inducing ligand for the potential treatment of autoimmune diseases. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was incorporated in 1993 and is headquartered in Edmonton, Canada.
Organization
Aurinia Pharmaceuticals
Employees
130
CEO
Mr. Peter S. Greenleaf M.B.A.
Industry
Health Technology

Management People of Aurinia Pharmaceuticals

NameTitle
Mr. Peter S. Greenleaf M.B.A.
CEO & Director
Mr. Matthew Maxwell Donley M.B.A.
Chief Operations Officer
Mr. Stephen P. Robertson
Executive Vice President of General Counsel
Ms. Andrea Levin Christopher
Head of the Corporate Communications & Investor Relations
Dr. Gregory F. Keenan M.D.
Chief Medical Officer
Dr. Premchandran Ramiya Ph.D.
Senior Vice President of Manufacturing & Supply Chain
Ms. DeDe Sheel
Vice President of Investor Relation

Important FAQs about investing in AUPH Stock from India :

What is Aurinia Pharmaceuticals share price today?

Aurinia Pharmaceuticals share price today stands at $8.67, Open: $8.10 ; Previous Close: $8.08 ; High: $8.83 ; Low: $8.18 ; 52 Week High: $10.67 ; 52 Week Low: $4.71.

The stock opens at $8.10, after a previous close of $8.08. The stock reached a daily high of $8.83 and a low of $8.18, with a 52-week high of $10.67 and a 52-week low of $4.71.

Can Indians buy Aurinia Pharmaceuticals shares?

Yes, Indians can invest in the Aurinia Pharmaceuticals (AUPH) from India.

With INDmoney, you can buy Aurinia Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Aurinia Pharmaceuticals at zero transaction cost.

How can I buy Aurinia Pharmaceuticals shares from India?

It is very easy to buy Aurinia Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Aurinia Pharmaceuticals (AUPH) be purchased?

Yes, you can buy fractional shares of Aurinia Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Aurinia Pharmaceuticals stocks?

To start investing in Aurinia Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Aurinia Pharmaceuticals Stock (AUPH)?

Today’s highest price of Aurinia Pharmaceuticals (AUPH) is $8.83.

Today’s lowest price of Aurinia Pharmaceuticals (AUPH) is $8.18.

What is today's market capitalisation of Aurinia Pharmaceuticals?

Today's market capitalisation of Aurinia Pharmaceuticals AUPH is 1.1B

What is the 52 Week High and Low Range of Aurinia Pharmaceuticals Stock (AUPH)?

  • 52 Week High

    $10.67

  • 52 Week Low

    $4.71

What are the historical returns of Aurinia Pharmaceuticals (AUPH)?

  • 1 Month Returns

    8.24%

  • 3 Months Returns

    25.47%

  • 1 Year Returns

    57.07%

  • 5 Years Returns

    -43.92%

Who is the Chief Executive Officer (CEO) of Aurinia Pharmaceuticals ?

Mr. Peter S. Greenleaf M.B.A. is the current Chief Executive Officer (CEO) of Aurinia Pharmaceuticals.